BNP Paribas Financial Markets
NXTC icon

BNP Paribas Financial Markets’s NextCure NXTC Stock Holding History

BNP Paribas Financial Markets’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51 Hold
32
– – ﹤0.01% 5827
2026
Q1 		$342 Hold
32
– – ﹤0.01% 5576
2025
Q4 		$454 Hold
32
– – ﹤0.01% 5486
2025
Q3 		$188 Hold
32
– – ﹤0.01% 5395
2025
Q2 		$177 Hold
32
– – ﹤0.01% 5291
2025
Q1 		$185 Hold
32
– – ﹤0.01% 5217
2024
Q4 		$297 Hold
32
– – ﹤0.01% 5212
2024
Q3 		$527 Hold
32
– – ﹤0.01% 4000
2024
Q2 		$612 Hold
32
– – ﹤0.01% 3891
2024
Q1 		$859 Hold
32
– – ﹤0.01% 3869
2023
Q4 		$439 Hold
32
– – ﹤0.01% 3900
2023
Q3 		$497 Hold
32
– – ﹤0.01% 3786
2023
Q2 		$693 Hold
32
– – ﹤0.01% 3787
2023
Q1 		$570 Sell
32
-14
-30% -$270 ﹤0.01% 3715
2022
Q4 		$780 Buy
46
+14
+44% +$322 ﹤0.01% 3831
2022
Q3 		$1.06K Sell
32
-33
-51% -$1.68K ﹤0.01% 4421
2022
Q2 		$3.64K Buy
65
+33
+103% +$1.72K ﹤0.01% 3845
2022
Q1 		$1.87K Hold
32
– – ﹤0.01% 3912
2021
Q4 		$2.31K Hold
32
– – ﹤0.01% 3985
2021
Q3 		$2.6K Sell
32
-144
-82% -$12.6K ﹤0.01% 3769
2021
Q2 		$16.9K Sell
176
-60
-25% -$6.14K ﹤0.01% 3579
2021
Q1 		$28.3K Sell
236
-121
-34% -$17.5K ﹤0.01% 3708
2020
Q4 		$46.7K Buy
357
+50
+16% +$6.46K ﹤0.01% 3586
2020
Q3 		$32.4K Buy
307
+256
+502% +$31.5K ﹤0.01% 3660
2020
Q2 		$13.2K Sell
51
-463
-90% -$176K ﹤0.01% 3590
2020
Q1 		$229K Buy
514
+378
+278% +$202K ﹤0.01% 2795
2019
Q4 		$92K Buy
136
+124
+1,033% +$62.2K ﹤0.01% 3330
2019
Q3 		$4.35K Buy
12
+11
+1,100% +$3.58K ﹤0.01% 4287
2019
Q2 		$210 Buy
+1
New +$208 ﹤0.01% 4454

Other funds holding NXTC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

BNP Paribas Financial Markets's NXTC Position: Q2 2026 in Review

BNP Paribas Financial Markets held its NextCure (NXTC) position steady in Q2 2026 at 32 shares worth $51. The position accounts for ﹤0.01% of the portfolio, ranked #5827.

BNP Paribas Financial Markets first reported a position in NXTC in Q2 2019 and has held it in 29 quarters since. The position peaked at $229K in Q1 2020. 17 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • BNP Paribas Financial Markets held 32 shares of NextCure worth $51 as of Q2 2026.
  • BNP Paribas Financial Markets left its NextCure share count unchanged in Q2 2026.
  • NextCure made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5827 holding.
  • BNP Paribas Financial Markets first reported a position in NextCure in Q2 2019 and has held it in 29 quarters since.
  • BNP Paribas Financial Markets's NextCure position peaked at $229K in Q1 2020.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.